Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
Franz Trautinger, Robert Knobler, Rein Willemze, et al.
European Journal of Cancer (2006) Vol. 42, Iss. 8, pp. 1014-1030
Closed Access | Times Cited: 408

Showing 26-50 of 408 citing articles:

A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome
Emma Benton, Siobhan Crichton, R. Talpur, et al.
European Journal of Cancer (2013) Vol. 49, Iss. 13, pp. 2859-2868
Closed Access | Times Cited: 143
Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2017) Vol. 92, Iss. 10, pp. 1085-1102
Open Access | Times Cited: 141
Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 151-165
Open Access | Times Cited: 139
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Julia Scarisbrick, Y.H. Kim, Sean Whittaker, et al.
British Journal of Dermatology (2014) Vol. 170, Iss. 6, pp. 1226-1236
Closed Access | Times Cited: 138
Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force
Julia Scarisbrick, Emmilia Hodak, M. Bagot, et al.
European Journal of Cancer (2018) Vol. 93, pp. 47-56
Open Access | Times Cited: 133
History of phototherapy in dermatology
Herbert Hönigsmann
Photochemical & Photobiological Sciences (2012) Vol. 12, Iss. 1, pp. 16-21
Closed Access | Times Cited: 127
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
Arun Alfred, Peter C. Taylor, Fiona L. Dignan, et al.
British Journal of Haematology (2017) Vol. 177, Iss. 2, pp. 287-310
Open Access | Times Cited: 125
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
Pietro Quaglino, Milena Maule, H. Miles Prince, et al.
Annals of Oncology (2017) Vol. 28, Iss. 10, pp. 2517-2525
Open Access | Times Cited: 122
The Stanford University Experience With Conventional-Dose, Total Skin Electron-Beam Therapy in the Treatment of Generalized Patch or Plaque (T2) and Tumor (T3) Mycosis Fungoides
Daniel Navi, Nadeem Riaz, Yakir S. Levin, et al.
Archives of Dermatology (2011) Vol. 147, Iss. 5, pp. 561-561
Closed Access | Times Cited: 120
Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2019) Vol. 94, Iss. 9, pp. 1027-1041
Open Access | Times Cited: 118
British Association of Dermatologists’ guidelines for the safe and effective prescribing of methotrexate for skin disease 2016
Richard B. Warren, Sophie Weatherhead, Catherine Smith, et al.
British Journal of Dermatology (2016) Vol. 175, Iss. 1, pp. 23-44
Open Access | Times Cited: 105
European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1
Robert Knobler, Petr Arenberger, Apoorva Arun, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 12, pp. 2693-2716
Open Access | Times Cited: 75
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 193-209
Open Access | Times Cited: 51
Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion
Chalid Assaf, M. Bagot, Reinhard Dummer, et al.
British Journal of Dermatology (2006) Vol. 155, Iss. 2, pp. 261-266
Closed Access | Times Cited: 127
How I treat mycosis fungoides and Sézary syndrome
H. Miles Prince, Sean Whittaker, Richard T. Hoppe
Blood (2009) Vol. 114, Iss. 20, pp. 4337-4353
Open Access | Times Cited: 127
Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma
Rafael F. Duarte, Norbert Schmitz, Octavio Servitje, et al.
Bone Marrow Transplantation (2008) Vol. 41, Iss. 7, pp. 597-604
Closed Access | Times Cited: 124
Extracorporeal photopheresis: Past, present, and future
Robert Knobler, Mark L. Barr, Daniel R. Couriel, et al.
Journal of the American Academy of Dermatology (2009) Vol. 61, Iss. 4, pp. 652-665
Closed Access | Times Cited: 121
Bexarotene therapy for mycosis fungoides and Sézary syndrome
Rachel Abbott, Sean Whittaker, Steven Morris, et al.
British Journal of Dermatology (2009) Vol. 160, Iss. 6, pp. 1299-1307
Closed Access | Times Cited: 113
Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sézary Syndrome
G. Quéreux, Sónia M Ribeiro Marques, Jean‐Michel Nguyen, et al.
Archives of Dermatology (2008) Vol. 144, Iss. 6
Closed Access | Times Cited: 103
Classification of cutaneous lymphomas – an update
Werner Kempf, Christian A. Sander
Histopathology (2009) Vol. 56, Iss. 1, pp. 57-70
Open Access | Times Cited: 100
Revisiting Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides
Cameron Harrison, James W. Young, Daniel Navi, et al.
International Journal of Radiation Oncology*Biology*Physics (2011) Vol. 81, Iss. 4, pp. e651-e657
Closed Access | Times Cited: 100
Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012
Reinhard Dummer, Pietro Quaglino, Jürgen C. Becker, et al.
Journal of Clinical Oncology (2012) Vol. 30, Iss. 33, pp. 4091-4097
Open Access | Times Cited: 99
Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma
Frederick Lansigan, Francine M. Foss
Drugs (2010) Vol. 70, Iss. 3, pp. 273-286
Closed Access | Times Cited: 98
Romidepsin for Cutaneous T-cell Lymphoma
H. Miles Prince, Michael Dickinson
Clinical Cancer Research (2012) Vol. 18, Iss. 13, pp. 3509-3515
Open Access | Times Cited: 93
Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma
Khaled Elsayad, Jan Kříž, Christos Moustakis, et al.
International Journal of Radiation Oncology*Biology*Physics (2015) Vol. 93, Iss. 5, pp. 1077-1086
Closed Access | Times Cited: 76

Scroll to top